MWM
AGN

Mascoma Wealth Management’s Allergan plc AGN Stock Holding History

Mascoma Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10
Closed -$2K – 380
2019
Q2 		$2K Hold
10
– – ﹤0.01% 353
2019
Q1 		$1K Hold
10
– – ﹤0.01% 386
2018
Q4 		$1K Hold
10
– – ﹤0.01% 368
2018
Q3 		$2K Hold
10
– – ﹤0.01% 375
2018
Q2 		$2K Hold
10
– – ﹤0.01% 376
2018
Q1 		$2K Buy
+10
New +$1.68K ﹤0.01% 356
2017
Q4 		– Sell
-3,680
Closed -$754K – 431
2017
Q3 		$754K Hold
3,680
– – 0.5% 30
2017
Q2 		$895K Hold
3,680
– – 0.6% 26
2017
Q1 		$879K Hold
3,680
– – 0.63% 25
2016
Q4 		$773K Buy
+3,680
New +$762K 0.57% 27

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Longview Partners
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Mascoma Wealth Management's AGN Position: Q3 2019 in Review

Mascoma Wealth Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 10 shares — an estimated $2K sold.

Mascoma Wealth Management first reported a position in AGN in Q4 2016 and held it in 10 quarters. The position peaked at $895K in Q2 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Mascoma Wealth Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Mascoma Wealth Management sold 10 Allergan plc shares in Q3 2019, an estimated $2K.
  • Mascoma Wealth Management first reported a position in Allergan plc in Q4 2016 and held it in 10 quarters.
  • Mascoma Wealth Management's Allergan plc position peaked at $895K in Q2 2017.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Mascoma Wealth Management's 13F filing for Q3 2019, filed 21 Nov 2019.